Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by Zonulolysis and cataract

被引:18
|
作者
Kralinger, MT
Kieselbach, GF
Voigt, M
Hayden, B
Hernandez, E
Fernandez, V
Pare, JM
机构
[1] Med Univ Innsbruck, Klin Augenheilkunde & Optometrie, Dept Ophthalmol, AT-6020 Innsbruck, Austria
[2] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Ophthalm Biophys Ctr, Miami, FL 33152 USA
[3] Humboldt Univ, Charite Hosp, Ophthal Clin Virchow, Berlin, Germany
[4] Univ Liege, CHU Sart Tilman, Dept Ophthalmol, Liege, Belgium
[5] Univ Paris, Hop Hotel Dieu, F-75252 Paris, France
关键词
dispase; experimental model; intravitreal injection; proliferative; vitreoretinopathy; cataract; zonulolysis;
D O I
10.1159/000093073
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method. Methods: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units. Results: Proliferative vitreoretinopathy occurred in 81 % of the treated eyes. In 90% cataract formation was observed. Lens luxation was present in 47.3% of the cataract eyes. Conclusion: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:211 / 216
页数:6
相关论文
共 50 条
  • [31] Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model
    Daftarian, Narsis
    Baigy, Omolbanin
    Suri, Fatemeh
    Kanavi, Mozhgan Rezaei
    Balagholi, Sahar
    Aski, Sasha Afsar
    Moghaddasi, Afrooz
    Nourinia, Ramin
    Abtahi, Seyed-Hossein
    Ahmadieh, Hamid
    EXPERIMENTAL EYE RESEARCH, 2021, 208
  • [32] A novel mouse model of proliferative vitreoretinopathy induced by intravitreal injection of gas and RPE cells
    Kuriyan, Ajay E.
    Heffer, Alison
    Wang, Victor
    Sridhar, Jayanth
    Feldon, Steven E.
    Libby, Richard T.
    Woeller, Collynn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [33] Intravitreal triamcinolone acetonide for the treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy
    Munir, WM
    Pulido, JS
    Sharma, MC
    Buerk, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U768 - U768
  • [34] SILICONE OIL IN AN EXPERIMENTAL-MODEL OF PROLIFERATIVE VITREORETINOPATHY (PVR)
    VANDERZEE, WAM
    LEAN, JS
    RYAN, SJ
    OPHTHALMOLOGICA, 1985, 190 (03) : 186 - 187
  • [35] Combined pharmacological therapy in an experimental model of proliferative vitreoretinopathy (PVR)
    Pastor, JC
    Rodriguez, E
    Marcos, MA
    Lopez, MI
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1845 - 1845
  • [36] DAUNORUBICIN TREATMENT IN A REFINED EXPERIMENTAL-MODEL OF PROLIFERATIVE VITREORETINOPATHY
    KHAWLY, JA
    SALOUPIS, P
    HATCHELL, DL
    MACHEMER, R
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1991, 229 (05) : 464 - 467
  • [37] Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy
    Berger, AS
    Cheng, CK
    Pearson, PA
    Ashton, P
    Crooks, PA
    Cynkowski, T
    Cynkowska, G
    Jaffe, GJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (11) : 2318 - 2325
  • [38] Experimental model of proliferative vitreoretinopathy with fetal lung fibroblasts.
    Cavero, LL
    GarciaArumi, J
    Sararols, L
    Huguet, P
    Calico, I
    VISION RESEARCH, 1996, 36 : 357 - 357
  • [39] Experimental model of proliferative vitreoretinopathy with blood mononuclears in rats.
    Zapuskalova, OB
    Krivosheina, OI
    Logvinov, SV
    Zapuskalov, IV
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S344 - S344
  • [40] The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice
    Gao, Qianying
    Wang, Wencong
    Lan, Yuqing
    Chen, Xiaoqing
    Yang, Wei
    Yuan, Yongguang
    Tan, Juan
    Zong, Yao
    Jiang, Zhaoxin
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 1563 - 1572